Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 31:13:1050-1063.
doi: 10.3762/bjoc.13.104. eCollection 2017.

New tricks of well-known aminoazoles in isocyanide-based multicomponent reactions and antibacterial activity of the compounds synthesized

Affiliations

New tricks of well-known aminoazoles in isocyanide-based multicomponent reactions and antibacterial activity of the compounds synthesized

Maryna V Murlykina et al. Beilstein J Org Chem. .

Abstract

The well-known aminoazoles, 3-amino-5-methylisoxazole and 5-amino-N-aryl-1H-pyrazole-4-carboxamides, were studied as an amine component in Ugi and Groebke-Blackburn-Bienaymé multicomponent reactions. The first example of an application of aminoazoles in an Ugi four-component reaction was discovered and novel features of a Groebke-Blackburn-Bienaymé cyclocondensation are established and discussed. The heterocycles obtained were evaluated for their antibacterial activity and several of them demonstrated a weak antimicrobial effect, but for most of the compounds a 30-50% increase in biomass of Gram-positive strains (mainly B. subtilis) compared to control was observed.

Keywords: 3-amino-5-methylisoxazole; 5-amino-N-aryl-1H-pyrazole-4-carboxamides; Groebke–Blackburn–Bienaymé reaction; antibacterial activity; isocyanide Ugi reaction.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Aminoazoles in GBB-3CR and Ugi-4CR.
Scheme 2
Scheme 2
Reactivity of 5-amino-N-aryl-1H-pyrazole-4-carboxamide and 3-amino-5-methylisoxazole in GBB-3CR and Ugi-4CR.
Figure 1
Figure 1
Alternative structures A and B for compounds 4 and 6.
Figure 2
Figure 2
Selected data of HSQC and HMBC experiments for compound 4a.
Figure 3
Figure 3
Molecular structure of 3-(tert-butylamino)-2-(4-chlorophenyl)-N-(4-fluorophenyl)-1H-imidazo[1,2-b]pyrazole-7-carboxamide (4e) (X-ray diffraction data). Non-hydrogen atoms are presented as thermal ellipsoids with 50% probability.
Figure 4
Figure 4
Selected data of NOE and HSQC experiments for compound 9d.
Figure 5
Figure 5
Molecular structure of N-(2-(tert-butylamino)-1-(4-chlorophenyl)-2-oxoethyl)-N-(5-methylisoxazol-3-yl)-3-phenylpropiolamide (9e) (X-ray diffraction data). Non-hydrogen atoms are presented as thermal ellipsoids with 50% probability.

References

    1. Gavins F, editor. Navigating the threat of antimicrobial resistance. Pharmacol. Matters. 2014;7 (3):1–26.
    1. Nordberg P, Monnet L D, Cars O. WHO project: Priority Medicines for Europe and the World. 2005. “A Public Health Approach to Innovation.”; pp. 1–40.
    1. Coates A, Hu Y, Bax R, Page C. Nat Rev Drug Discovery. 2002;1:895–910. doi: 10.1038/nrd940. - DOI - PubMed
    1. Carlet J, Jarlier V, Harbarth S, Voss A, Goossens H, Pittet D. Antimicrob Resist Infect Control. 2012;1:No. 11. doi: 10.1186/2047-2994-1-11. - DOI - PMC - PubMed
    1. Scott M G, Davidson D J, Gold M R, Bowdish D, Hancock R E W J. J Immunol. 2002;169:3883–3891. doi: 10.4049/jimmunol.169.7.3883. - DOI - PubMed